Mar 2024 |
Attend 2024 BIO Europe and one-on-one partnering. |
Dec 2023 |
NRT was awarded the 20th National Innovation Award in the Academic Research Category.
|
Dec 2023 |
NRT won the Outstanding Team Award at the 2023 NBRP Pitch Day.
|
Dec 2023 |
Participated Healthcare+ Expo Taiwan 2023 exhibition and demonstrated our new drug research and
development progress.
|
Oct 2023 |
Attended 2023 CTAD Congress and presented our recent progress of preclinical studies. |
Oct 2023 |
Participated 2023 BIO Japan and one-on-one partnering. |
Jul 2023 |
Attended 2023 BIO Asia-Taiwan and demonstrated our new drug research and development progress. |
Jul 2023 |
Joined the online Alzheimer's Association International Conference (AAIC) 2023. |
Jun 2023 |
Attended 2023 BIO International Convention and one-on-one partnering. |
May 2023 |
Participated 2023 NBRP DEMO DAY and presented our recent progress of preclinical studies.
|
Dec 2022 |
The “A New Dawn for the Treatment of Schizophrenia” project won
the 2022 Future Tech Award.
|
Dec 2022 |
Attended 2022 CTAD Congress and present our recent progress of preclinical studies.
|
Nov 2022 |
Attended Neuroscience 2022 held by Society for Neuroscience and presented our results of preclinical
studies.
|
Oct 2022 |
Participated 2022 BIO Japan and partnering. |
July 2022 |
Attended 2022 BIO Asia-Taiwan and demonstrated our new drug research and development progress.
|
July 2022 |
Participated 2022 BIO Asia-Taiwan 3-min Elevator Pitch competition.
|
April 2022 |
Participated 2022 NBRP DEMO DAY and presented our progress in research and made connections with
investors, global pharma R&D experts, talents, and partners in this field.
|
Nov 2021 |
Attended business plan writing workshop held by NBRP Academy and presented in the pitch competition
at 2021 BIO Asia-Taiwan. Our team won the Best Investment Target Award.
|
Nov 2021 |
參與14th Asia Pacific Federation of Pharmacologists (APFP)及發表研究成果 |
Nov 2021 |
Attended 14th Asia Pacific Federation of Pharmacologists (APFP) and presented our research work.
|
Nov 2021 |
Attended 2021 Clinical Trials on Alzheimer's Disease (CTAD) Congress and presented our results
of preclinical studies.
|
July 2021 |
Represented BioTReC as one of the translational medicine incubation teams and was interviewed
by the Global Bio & Investment Monthly (July 2021) to present and promote our project to
the public.
|
April 2021 |
Participated and presented our project of new drug development in 2021 NBRP DEMO DAY and won
the top Institute Potential Gold Award out of 50 participants in the Biomedical Innovation
Achievement Exhibition.
|